Integrating radiopharmaceuticals and radioligand therapy (RLT) into clinical trials presents several operational challenges. As a result, several protocol decisions require significant forethought and careful planning. Despite the complexity, strategic decisions can greatly enhance treatment opportunities.
Read our white paper to learn about RLT implementation, including:
- Protocols designed to address unique regulatory requirements
- Specialized operational strategies and logistics for RLT production, transport, and handling
- The importance of site readiness, vendor management, and risk mitigation
